Shares of Universal Technical Institute (UTI) are soaring 5.07% in intraday trading on Friday, following a positive analyst update. The surge comes as Truist Securities raised its price target on the stock, signaling growing confidence in the company's prospects.

Truist Securities adjusted its price target for UTI from $32 to $37, representing a significant increase in their valuation of the company. The firm also maintained its Buy rating on the stock, reaffirming their bullish stance. This upward revision appears to have sparked investor enthusiasm, driving the stock's impressive gain.

The positive sentiment is not limited to Truist Securities alone. According to data from FactSet, the average rating for Universal Technical Institute among analysts is Buy, with a mean price target of $35.33. This consensus bullish outlook suggests that Wall Street sees substantial upside potential in UTI shares, which may be contributing to today's rally. Investors seem to be responding favorably to these optimistic projections, pushing the stock higher as they reassess its value in light of the analyst updates.